http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
족과관절염좌 환자에 대한 동씨침법과 일반침법의 효과에 대한 비교 연구
안호진,정동화,황규선,윤기붕,김태우,문장혁,백종엽,이상무,Ahn, Ho-jin,Jeong, Dong-hwa,Hwang, Kyu-seon,Yoon, Ki-bung,Kim, Tae-woo,Moon, Jang-huyk,Baek, Jong-yeob,Lee, Sang-moo 대한침구의학회 2003 대한침구의학회지 Vol.20 No.1
Objective: The purpose of this study is to compare the effects of Dong-si acupuncture therapy and General acupuncture therapy for the patients with acute ankle sprain. Methods : This study has been carried out for 60 cases of ankle sprain patients who have visited Dong-Seo Oriental medical Hospital from May 1, 2002 to September 30, 2002. We have treated 30 cases of them by Dong-si acupuncture therapy and the other 30 cases by General acupuncture therapy. And we have compared those two group. Results : 1. There was no significant difference at the treatment period and the number of treatment times in comparing two groups. 2. The number of treatment times for good effect is that : Dong-si took $1.57{\pm}0.85$ times and General acupuncture therapy took $2.15{\pm}0.96$ times. And we have found that the effect of Dong-si acupuncture therapy is faster than the other.
봉독(蜂毒)의 연구 경향에 대한 분석 -국내 학위논문 중 봉독에 관한 연구를 중심으로-
박장우 ( Jang Woo Park ),허동석 ( Dong Seok Heo ),윤일지 ( Il Ji Yoon ),오민석 ( Min Seok Oh ) 한방재활의학과학회 2006 한방재활의학과학회지 Vol.16 No.2
Objectives : To research the trend of the study related to bee venom and to establish the hereafter direction for the study on bee venom therapy. Methods : I referred to national assembly library and national library of Korea, with `bee venom`, `apitoxin`, `apitherapy`, `bee sting`. After collecting all the theses about bee venom published by domestic university from 1992 to 2005, I figured out number and percentage of theses according to university, year, major field of study, subject. In case of subject, I classified and analyzed it with anti-inflammation effect;travail effect;immunity relation;safe treatment & prevention of side effect of bee venom. Results : The following results were obtained in this study. 1. In the arrangement by the year, the theses started to publish after 1992, and the number of theses has been increasing rapidly since 2000. And it has been decreasing since gaining the summit at 2003. 2. Classified by university, Kyung-Hee University published the most theses, and other theses were published by Kyung-Won University, Dong-Guk University, Kyoung-San University, Seoul National University order. 3. Classified by the major field of study, number of theses was the most by 69 in oriental medicine, next, it was 8, 2 in veterinary science and medicine. 4. Analyzed by the subject, numbers of theses that is related to anti-inflammation effect are 39(50%), numbers of theses related to travail effect are 15(18%), numbers of theses related to immunity are 19(23%), numbers of theses related to safty are 7(8%). 5. Theses that is related to anti-inflammation effect ; travail effect of bee venom shaded to mechanism study inclination after 2002 in primitive effect proof study inclination. Theses that is related to immunity of bee venom shaded to anticancer-related research inclination after 2000 in primitive immunity promotion effect study inclination. 6. In the study for safe treatment & prevention of side effect of bee venom, there were reports bee venom secures when it is injected in wide region, by low concentration, in 3 days cycle. 7. Theses related to bee venom are for the most part experiment theses by 76. Conclusions : As see in above result, safety of bee venom was proved, I think that the more clinical access by using bee venom should be achieved because objective, scientific basis was readied for effect of anti-inflammation, travail, immunity promotion, anticancer etc.
녹동균 세포외막 단백질 백신 CFC-1-101의 안정성 및 면역원성 검토 : 임상 제 Ⅰ/Ⅱa상 시험
장인진,김익상,유경상,임동석,김형기,신상구,장우현,박완제,이나경,정상보,안동호,조양제,안보영,이윤하,김영지,남성우,김현수 대한감염학회 1998 감염 Vol.30 No.3
목적 : 제일제당에서는 녹농균의 세포외막 단밸질을 유효성분으로 하는 백신인 CFC-101을 개발하였으며, 동물시험에서 이 백신의 안전성과 유효성을 입증하였다. 본 연구에서는 이 녹농균 백신의 인체에 대한 안전성과 면역원성을 평가하는 동시에 인체 접종시의 최적 투여 용량을 결정하기 위하여 제 I/Ⅱa상 임상시험을 수행하였다. 방법 : 건강한 성인 남자를 피험자로 선별하여 각 용량군에 백신투여자 6명, 위약투여자 2명을 배정하였다. 백신 투여군은 0.25mg, 0.5mg 또는 1.0mg 용량의 녹농균 백신을 7일 간격으로 3회에 걸쳐 근육주사 하였으며, 위약 투여군에게는 세포외막 단백질을 제외한 동일한 성분을 투여하였다. 백신접종 후 국소적 또는 전신적인 반응의 발생여부를 관찰하고, 혈액시료를 체취하여 백신의 역가와 유효성을 검정하였다. 결과 : 녹농균 백신 CFC-101은 모든 접종자에서 양호한 내약성을 보였다. 또한 0.5mg 과 1.0mg 백신 투여군에서는 100%의 항체양전율을 나타내었다. 생성된 항체는 녹농균 세포외막단백질에 특이성을 보였고, 녹농균 감염에 대해 방어효능이 있었다. 결론 : 이와같은 결과로부터 이 녹농균 백신은 인체에 안전하게 투여할 수 있으며, 높은 항체 생성능으로 감염방어 효능을 보이고 0.5mg과 1.0mg이 최적용량인 것으로 판단되었다. Background : We developed a Pseudomonas aeruginosa outer membrane protein(OMP) vaccine CFC-101, and the prophylactic efficacy of which has been demonstrated in animal models. In order to evaluate the safety and immunogenicity of the P. aeruginosa vaccine, we carried out a phase I/Ⅱa clinical trial in healthy male volunteers. Methods : Groups of eight volunteers, including two placebo subjects, were vaccinated intramuscularly with three doses of 0.25, 0.5 or 1.0 mg of the vaccine at one week intervals. Sings of systemic and local reactions observed after vaccination were recorded for each vaccinee for 5 days. Physical examinations were performed on days 0, 1, 7, 8, 14, 15, 21, and 42, and clinical laboratory tests were done on days 0, 3, and 21. Blood samples for assay of serum antibody levels were obtained up to 42 days after the first vaccination. Results : The vaccine was generally well tolerated by all vaccinees, showing no significant side effects. In the three dosage groups, all vaccinees, except one receiving the 0.25 mg dose, showed significant elevation in serum IgG antibody titers against the vaccine proteins, indicating 100% seroconversion in 0.5 and 1.0 mg groups. The human antibodies induced by the vaccine were specific for P. aeruginosa OMPs, as confirmed by western blot analysis and immunoprecipitation assays. The capacity of the human antisera to enhance opsonophagocytic killing activity by polymorphonuclear leukocytes and to confer protection against P. aeruginosa infections indicates that the antibodies elicited by the vaccine have protective efficacy. Conclusion : We conclude that the P. aeruginosa OMP vaccine is safe and effective for human use and its optimal dose to be 0.5 or 1.0 mg.
아급성 Ethanol 중독시 고뇨산혈증에 미치는 Pyrazinamide의 영향
장윤경,강우규,김동훈,최종원 慶星大學校 環境問題硏究所 1992 環境硏報 Vol.2 No.1
Ethanol 투여후 pyrazinamide 처리로 유도되어지는고 뇨산혈증의 발생 기전과 규명하고자 ethanol을 rat에 아급성적으로 투여하고 pyrazinoic acid의 대사 과정, 뇨산의 혈증 농도, 뇨산의 생합성 및 분해과정에 관여하는 효소의 활성 변화를 비교검토하였을 때 pyrazina-mide의 대사산물인 pyazinoic acid의 생성과정은 증가되었으나 pyrazinoic acid의 분해과정은 영향이 없었다. Ethanol 아급성 중독상태에 pyrazinamide를 투여하였을 때 혈액중의 뇨산 농도는 대조군에 비해 약 123% 정도현저히 증가되었다. 뇨산의 분해 효소인 urixase의 활성변화와 생합성에 관여하는 adenosine deaminase, purine nucleoside phos-phorylase 및 guanine deaminase의 활성변화에는 별다른 관련성이 없었으며 선책적으로 xanthine oxidase 활성만이 유도되어 나타나는 결과였다. In the present work, the purpose was to onbserve the effect of subacute ethanol intoxication on the changes of purine metabnolic pathway after pyraxzinamide administration in rats. In vitro test, it was observed that pyrazinamide deaminasing-enzyme activity was significantly increased and pyrazinoic acid oxidizing-enzyme activity was not affected by ethanol-administrated rat's cytosolic liver. When uric acid level in blood was estimated after pyrazinamide treatment, the blood level was increased in comparison to control group of subacute ethanol intoxication. Ethanol administration did not affect activities of guanine deaminase, adenosine deaminase, purine nucleoside phosphorylase and uricase, on the other hand, xanthing oxidase activity was significantly increased as compared with control. These results suggest that hyperuricemia incuced by the administration of pyrazinamide after subacute ethanol intoxication may be result from the selective increase of xanthine oxidase activity.
Jang-Ho Lee,Joon-Soo Lee,Woo-Saeng Kwon,Je-Yong Kang,Dong-Yun Lee,Jun-Gyo In,Yun-Soo Kim,Jiho Seo,In-Ho Baeg,Il-Moo Chang,Keith Grainger 고려인삼학회 2015 Journal of Ginseng Research Vol.39 No.2
Background: Ginseng (Panax ginseng Meyer) is an important medicinal herbs in Asia. However, ginsengvarieties are less developed. Method: To developed ginseng varieties, a pure line selection method was applied in this study. Results: Gumpoong was testing of 4-yr-old specimens in 2002, the proportions of the below-groundroots that were rusty colored for Gumpoong was 1.29 in Daejeon and 1.45 in Eumseong, whereas theproportions for its yellow berry variant were 2.60 and 2.45 in the two regions, respectively. Thus theGumpoong was resistant to root rust. Sunpoong has a high yielding property. Its average root weight is70.6 g for 6-yr-old roots. Its yield is 2.9 kg/1.62m2 and the rate of heaven- and earth-grade product is20.9%, which is very high compared to 9.4% for Yunpoong. Sunone is resistance to root rot and thesurvival rate of 4-yr-old roots was 44.4% in 1997, whereas that of the violet-stem variant landrace was21.7%. Sunhyang has content of arginyl-fructosyl-glucose (AFG), which produces the unique scent of redginseng, is 95.1 mmol/g and greater than the 30.8 mmol/g of Chunpoong in 6-yr-old plants. Sunun andCheongsun are being nurtured to protect genetic resources. Conclusion: Developed ginsneg varieties will be used as the basis for the protection of genetic resourcesand breeding. Jang-Ho Lee
레토르트 파우치 포장을 이용한 칡즙의 저장 중 항산화 활성의 변화
김동호, 우인혜, 조혜지, 장금일 忠北大學校 農業科學硏究所 2013 農業科學硏究 Vol.29 No.1
The changes of antioxidant activities during storage of arrowroot juice by retort pouch packaging (AJRP) were investigated. The antioxidant activities of arrowroot juice such as polyphenol content (TPC), DPPH and ABTS radical scavenging activities (DPPHRS and ABTSRS) were analyzed during storage at 4oC and 25oC for 30 days. 0 day, TPC, DPPHRS and ABTSRS were 7.8 mg gallic acid equivalent( GAE)/mL juice, 3.7 mg ascorbic acid eqivalent(AE)/mL juice, and 11.5 mg ascorbic acid equivalent/ mL juice, respectively. In the storage for 30 days, TPC, DPPHRS and ABTSRS of PET+CPP packaging arrowroot juice (control) showed 7.6 mg GAE/mL juice, 3.5 mg/ AE/mL juice, 11.3 mg AE/mL juice at 4oC, respectively and 7.4 mg GAE/mL, 3.3 mg/ AE/mL, 10.6 mg AE/mL at 25oC, respectively. Whereas all antioxidant activities such as TPC, DPPHRS and ABTSRS of AJRP were consistently maintained. In conclusion, the storage of arrowroot juice with retort pouch film packaging was effective for maintaining antioxidant activities at various temperatures.